3 active not recruiting, 3 recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Active not recruiting 3, Recruiting 3 |
| Phase 1 | 1 | Recruiting 1 |
Follow DMD: new trials by email Literature Review of DMD trials Research Report on DMD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients VM100 Nutritional Supplement - Duchenne Muscular Dystrophy, Duchenne Disease | Phase 2 | Recruiting | University of Florida | 20 | 2026-07-27 | 2026-10-08 |
| Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients SAT-3247, Placebo - Duchenne Muscular Dystrophy, Duchenne | Phase 2 | Active not recruiting | Satellos Bioscience, Inc. | 51 | 2025-12-08 | 2026-10-02 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy. Single dose intravenous of BBM-D101 - DMD | Phase 1 / Phase 2 | Recruiting | Belief BioMed (Beijing) Co., Ltd | 9 | 2025-07-31 | 2025-12-04 |
| Vasodilator and Exercise Study for DMD (VASO-REx) Tadalafil, Placebo, Exercise Training - Duchenne Muscular Dystrophy, Duchenne Disease | Phase 2 | Recruiting | University of Florida | 50 | 2024-06-05 | 2026-05-15 |
| NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD) NS-089/NCNP-02 - Duchenne Muscular Dystrophy, Exon 44 | Phase 2 | Active not recruiting | NS Pharma, Inc. | 20 | 2024-02-22 | 2026-09-15 |
| Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping AOC 1044 - DMD, Duchenne Muscular Dystrophy | Phase 2 | Active not recruiting | Avidity Biosciences, Inc. | 39 | 2024-01-22 | 2026-07-30 |
Muscular Dystrophy, Duchenne (5) · Muscular Dystrophies (3) · Tabes Dorsalis (2) · Aneurysm (1) · Fatigue (1) · Motor Activity (1) · Neuromuscular Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5) · Genetic Diseases, Inborn (5) · Genetic Diseases, X-Linked (5) · Muscular Diseases (5) · Muscular Disorders, Atrophic (5) · Musculoskeletal Diseases (5) · Nervous System Diseases (5) · Neuromuscular Diseases (4) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Central Nervous System Bacterial Infections (2) · Central Nervous System Diseases (2) · Central Nervous System Infections (2) · Gram-Negative Bacterial Infections (2) · Infections (2)
University of Florida (2) · Avidity Biosciences, Inc. (1) · Belief BioMed (Beijing) Co., Ltd (1) · NS Pharma, Inc. (1) · Satellos Bioscience, Inc. (1)
United States (5) · Australia (2) · Canada (2) · Belgium (1) · China (1) · Japan (1) · New Zealand (1) · Poland (1) · Serbia (1) · South Korea (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Carmen Castrillo, MD (1) · Tanja Taivassalo, MD (1) · Tanja Taivassalo, Ph.D. (1) · Yi Dai, MD (1)
2025 (1), R21AR079755 (1)